Skip to content

Ex-Vivo Lung Reconditioning

Pilot Study of Lung Transplantation After Ex-Vivo Lung Reconditioning

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02906436
Acronym
ExVivo
Enrollment
45
Registered
2016-09-20
Start date
2011-02-28
Completion date
2016-11-30
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Transplantation

Keywords

Lung transplantation, ExVivo reconditionning

Brief summary

Only about 15% of the potential candidates for lung donation are considered suitable for transplantation. Thus, a strategy that could improve the quality and precision of assessment of nonacceptable donor lungs could have a major impact on reducing waiting time and mortality while on the list. A new method for ex vivo lung perfusion (EVLP) has been developed recently by Steen and colleagues to assess the quality of lungs from a non-heart-beating donor. The method can also be used to recondition marginal and nonacceptable donor lungs. After harvesting, the lungs were perfused ex vivo with Steen Solution, an extracellular matrix with high colloid osmotic pressure. A membrane oxygenator connected to the circuit received gas from a mixture of nitrogen and carbon dioxide, maintaining a normal mixed venous blood gas level in the perfusate. The lungs were gradually rewarmed, reperfused, and ventilated for evaluation through analyses of oxygenation capacity, pulmonary vascular resistance (PVR), lung compliance (LC), and biopsy.

Interventions

DEVICEXvivo Chamber

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients on the waiting list for lung transplantation and for which the Biomedicine -Agency has awarded a lung transplantation after Ex-Vivo lung reconditioning * Patients affiliated to a social security system; * Patients who consented to participate in writing

Exclusion criteria

-Patients under tutorship or unable to consent or institutionalized

Design outcomes

Primary

MeasureTime frame
number of transplantable grafts and Reduced waiting time before transplantation12 months

Secondary

MeasureTime frame
Difference of data obtained 2 hours after Ex-Vivo lung reconditioning with those obtained 4 hours after Ex-Vivo lung reconditioning4 hours after Ex-Vivo lung reconditioning
Number of deaths of patients on waiting list5 years
survival time after lung transplantation with ExVivo lung reconditioning1 year after end of study
Quality of life scale score after lung transplantation with ExVivo lung reconditioning1 year after end of study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026